Clinical

The AJMC^® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care^® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

By Mario Enrico Canonico, MD, PhD
Judith Hsia, MD

August 14th 2025

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and implications for research.

Genetic factors may increase the risk of developing dilated cardiomyopathy in addition to covariates like age and sex. | Image Credit: AdobeStock_jaojormami.jpeg

Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation

By Sabrina McCrear

August 13th 2025

Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients

By Pierantonio Russo, MD
Henriette Coetzer, MD

August 13th 2025

Hospital exterior | Image Credit: Spiroview Inc. - stock.adobe.com

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

By Brooke McCormick

August 13th 2025

Care Quality Metrics in Medicare During COVID-19 Pandemic

By Jeanette Thornton, MPA
Mark Hamelburg, JD

August 12th 2025

More News

Impact of Maintenance Therapy in Multiple Myeloma

June 28th 2019

Watch

Strategy for Up-front Therapy of Multiple Myeloma

June 28th 2019

Watch

Backbone Therapy in Newly Diagnosed Multiple Myeloma

June 28th 2019

Watch

How Real-World Data Can Address Problems in MM

June 28th 2019

Watch

$Dosing Strategies in Relapsed-Refractory MM$

Dosing Strategies in Relapsed-Refractory MM

June 28th 2019

Watch

$Initiating Treatment in Relapsed-Refractory MM$

Initiating Treatment in Relapsed-Refractory MM

June 28th 2019

Watch

What Is the Cost of Recurrence in Multiple Myeloma?

June 28th 2019

Watch

Daratumumab in the Treatment Landscape for MM

June 28th 2019

Watch

Clinical Significance of MRD Testing in MM

June 28th 2019

Watch

Practical Implications of the MAIA Study for MM

June 28th 2019

Watch

Considerations for Transplant-Ineligible Patients

June 28th 2019

Watch

NCCN Guidelines for Newly Diagnosed MM

June 28th 2019

Watch

Achieving the Best Outcomes for Patients With MM

June 28th 2019

Watch

Cost Considerations of Multidrug Regimens in MM

June 28th 2019

Watch

Factoring Age Into Frontline Therapy for MM

June 28th 2019

Watch

Individualizing Therapy for Multiple Myeloma Patients

June 28th 2019

Watch

June Halper Outlines the Biggest Management Challenges in Multiple Sclerosis

June 22nd 2019

The biggest clinical challenges that we have in treating multiple sclerosis are 2-fold, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.

Watch

Evaluating Use of Bone-Modifying Agents to Treat Skeletal-Related Events in Cancer

Laura Joszt, MA

June 15th 2019

Skeletal-related events are frequent complications in patients with cancers. Two abstracts analyzed the use of bone-modifying agents in patients with newly diagnosed multiple myeloma and breast cancer.

Identifying Biomarkers to Predict Disease Severity, Progression, and Cognitive Impairment in MS

Laura Joszt, MA

June 6th 2019

Two abstracts presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers analyzed biomarkers to predict progression, disease severity, and cognitive impairment in multiple sclerosis (MS).